Soussain C, Malaise D, Choquet S, Ghesquieres H, et al. Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral L Eur J Cancer 2023;189:112909.
PMID: 37301714